
Statement by Ralph G. Neas, President and CEO, GPhA, Regarding IMS Findings on the Use of Medicines in 2013
PRESS RELEASE
WASHINGTON, DC, (April 16, 2014) — “The Generic Pharmaceutical Association (GPhA) welcomes this year’s IMS Institute for Healthcare Informatics report showing the critical role of generic medicines in saving billions of dollars for the health system and the economy. The study finds that even as utilization of medical services increased, the cost of medicines went up by just 3.2%, a historically low rate.
The low rate of spending on medicines in 2013 is a testament to the ongoing impact of generic drugs. This study reinforces that by relying on generic medicines, we can help ensure that as more Americans access medical services, the costs of medicines can be kept in check. This principle is critical for the coming year, as the number of insured Americans increases as a result of the Affordable Care Act.
The report,
Indeed, an
This report demonstrates the positive effect that generic medicines have had to date, but we can do even more. GPhA continues to call on Congress to enact common-sense reforms to save billions more for American taxpayers. This includes passing legislation to curb the abuse of the FDA’s Risk Evaluation and Mitigation Strategies (REMS) programs, which are being used to hinder competition, and measures to increase generic drug use for the Medicare Low Income Subsidy (LIS) population. According to CBO, this could result in more than $20 billion in savings to the federal government.”
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































